financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of Apple Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of Apple Inc.
Jun 21, 2024 5:27 AM

08:10 AM EDT, 06/21/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We up our 12-month target to $240 from $210 on a P/E of 29x but shifting to our CY 26 EPS of $8.28 (based on CY 25 prior). We keep our FY 24 (Sep.) EPS at $6.56 and raise FY 25 to $7.23 from $7.10. We initiate FY 26 at $8.10. As we look ahead to the iPhone 16 launch this fall, we are growing more confident that consensus views remain too low as we see upside to our iPhone unit assumptions (3%-5% growth). We expect Apple Intelligence (AI) to help support incremental consumer upgrades, driven by loyalists and an aging installed base, with AI being more evolutionary than cyclical that will aid multiple years of growth. Also, we think AAPL has an opportunity to boost prices this fall, although our model doesn't currently forecast ASP growth. While we acknowledge AAPL's valuation has become more stretched since the post-WWDC run, we are extremely excited about the experiences that developers will be able to create, supporting Services growth and belief that the iPhone can become the ultimate personal assistant.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Sell Opinion On Shares Of Edison International
Research Alert: CFRA Maintains Sell Opinion On Shares Of Edison International
Oct 31, 2025
11:30 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target remains $48, 7.8x our 2026 EPS estimate (down $0.05 to $6.08; 2025 estimate remains $6.03), a wide discount to peers based on weaker growth expectations vs. peers...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Southern Copper Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Southern Copper Corporation
Oct 31, 2025
11:10 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $55 to $151, driven by an EV/EBITDA multiple of 14.5x applied to our 2027 EBITDA estimate, which is a premium to SCCO's three-year...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Edwards Lifesciences Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Edwards Lifesciences Corporation
Oct 31, 2025
11:40 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price to $100 from $93, 35x our 2026 EPS and a slight premium to the company's long-term average forward P/E. We lift our 2025 EPS...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dexcom, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dexcom, Inc.
Oct 31, 2025
11:35 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target to $77 from $89, about 32x our 2026 EPS, below DXCM's average forward P/E and slightly under MedTech peers. We lift our 2025 EPS by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved